Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

Index by Author

November/December 2011; Volume 65,Issue 6

Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1–3, 2010

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Alves, Washington

    1. You have access
      Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
      Mark Moody, Washington Alves, Jose Varghese and Fazal Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 580-588; DOI: https://doi.org/10.5731/pdajpst.2011.00824

B

  1. Blümel, Johannes

    1. You have access
      Current European Regulations for Control of Adventitious Virus Safety
      Johannes Blümel
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 568-579; DOI: https://doi.org/10.5731/pdajpst.2011.00821
  2. Brorson, Kurt

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820
    2. You have access
      Summary of Breakout Session E
      Kurt Brorson and Anthony Lubiniecki
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 616-619; DOI: https://doi.org/10.5731/pdajpst.2011.00828
  3. Byrnes, Andrew P.

    1. You have access
      Breakout Session C Summary: Current Virus Detection Methods
      Andrew P. Byrnes and Hannelore Willkommen
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 660-662; DOI: https://doi.org/10.5731/pdajpst.2011.00835

C

  1. Cazeault, Chantal

    1. You have access
      Summary of Breakout Session B: Regulatory Expectations for CGMP
      Robert Sausville and Chantal Cazeault
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 713-714; DOI: https://doi.org/10.5731/pdajpst.2011.00847
  2. Cherney, Barry

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820
    2. You have access
      Application of Quality by Design in the Control of Adventitious Viruses: Gaps in Current Processes in the Prevention of Virus Contaminants
      Barry Cherney
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 754-766; DOI: https://doi.org/10.5731/pdajpst.2011.00849
  3. Clouse, Kathleen

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820

D

  1. Dehghani, Houman

    1. You have access
      Evaluation of a Single-Platform, Rapid, Nucleic Acid–Based Technology for Detection of Adventitious Contaminants of Cell Culture
      Houman Dehghani, Bill Lawrence and Richard C. Ill
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 675-680; DOI: https://doi.org/10.5731/pdajpst.2011.00840
  2. Donaldson, John

    1. You have access
      Nanostring's nCounter—A True Digital Target Profiling Technology
      Michael Morrow and John Donaldson
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 692; DOI: https://doi.org/10.5731/pdajpst.2011.00841
  3. Drews, Roman

    1. You have access
      Breakout Session A: Elimination or Treatment of High-risk Raw Materials
      Robert Kiss and Roman Drews
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 767-777; DOI: https://doi.org/10.5731/pdajpst.2011.00850
  4. Duncan, P.

    1. You have access
      Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus
      C. S. Ranucci, T. Tagmyer and P. Duncan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 589-598; DOI: https://doi.org/10.5731/pdajpst.2011.00827

E

  1. Eltermann, John

    1. You have access
      Adventitious Agents: Issues and Considerations during Pre-Approval Reviews and Inspections
      John Eltermann
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 694-697; DOI: https://doi.org/10.5731/pdajpst.2011.00845

F

  1. Farshid, Mahmood

    1. You have access
      Viral Safety of Plasma-derived Products
      Mahmood Farshid
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 737-753; DOI: https://doi.org/10.5731/pdajpst.2011.00848
  2. Friedman, Richard L.

    1. You have access
      FDA Post-Approval Expectations for Adventitious Virus Contamination Prevention
      Richard L. Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 698-712; DOI: https://doi.org/10.5731/pdajpst.2011.00846
  3. Friedman, Rick

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820

G

  1. Gardner, Shea

    1. You have access
      Detection of Adventitious Viruses from Biologicals Using a Broad-Spectrum Microbial Detection Array
      Crystal Jaing, Shea Gardner, Kevin McLoughlin, James B. Thissen and Tom Slezak
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 668-674; DOI: https://doi.org/10.5731/pdajpst.2011.00838
  2. Gregersen, Jens-Peter

    1. You have access
      Theory and Practice of Conventional Adventitious Virus Testing
      Jens-Peter Gregersen
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 634-644; DOI: https://doi.org/10.5731/pdajpst.2011.00832

H

  1. Hendricks, Linda C.

    1. You have access
      Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
      Linda C. Hendricks and Dominick A. Vacante
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 612-613; DOI: https://doi.org/10.5731/pdajpst.2011.00825
  2. Hughes, Patricia

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820
    2. You have access
      Introduction to Workshop: Adventitious Viruses in Biologics—Detection and Mitigation Strategies
      Arifa S. Khan, Patricia Hughes and Michael Wiebe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 544-546; DOI: https://doi.org/10.5731/pdajpst.2011.00817

I

  1. Ill, Richard C.

    1. You have access
      Evaluation of a Single-Platform, Rapid, Nucleic Acid–Based Technology for Detection of Adventitious Contaminants of Cell Culture
      Houman Dehghani, Bill Lawrence and Richard C. Ill
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 675-680; DOI: https://doi.org/10.5731/pdajpst.2011.00840

J

  1. Jaing, Crystal

    1. You have access
      Detection of Adventitious Viruses from Biologicals Using a Broad-Spectrum Microbial Detection Array
      Crystal Jaing, Shea Gardner, Kevin McLoughlin, James B. Thissen and Tom Slezak
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 668-674; DOI: https://doi.org/10.5731/pdajpst.2011.00838
  2. Jones, Nathan

    1. You have access
      Identification and Remediation of a Cell Culture Virus Contamination
      Nathan Jones
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 615; DOI: https://doi.org/10.5731/pdajpst.2011.00822

K

  1. Khan, Arifa S.

    1. You have access
      Current Testing Methods and Challenges for Detection of Adventitious Viruses
      Arifa S. Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 627-633; DOI: https://doi.org/10.5731/pdajpst.2011.00831
    2. You have access
      Introduction to Workshop: Adventitious Viruses in Biologics—Detection and Mitigation Strategies
      Arifa S. Khan, Patricia Hughes and Michael Wiebe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 544-546; DOI: https://doi.org/10.5731/pdajpst.2011.00817
    3. You have access
      Detection of Latent Retroviruses in Vaccine-related Cell Substrates: Investigation of RT Activity Produced by Chemical Induction of Vero Cells
      Hailun Ma and Arifa S. Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 685-689; DOI: https://doi.org/10.5731/pdajpst.2011.00843
  2. Khan, Fazal

    1. You have access
      Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
      Mark Moody, Washington Alves, Jose Varghese and Fazal Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 580-588; DOI: https://doi.org/10.5731/pdajpst.2011.00824
  3. King, Kathryn

    1. You have access
      PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document—A Progress Report
      Kathryn King and Michael Wiebe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 693; DOI: https://doi.org/10.5731/pdajpst.2011.00844
  4. Kiss, Robert

    1. You have access
      Breakout Session A: Elimination or Treatment of High-risk Raw Materials
      Robert Kiss and Roman Drews
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 767-777; DOI: https://doi.org/10.5731/pdajpst.2011.00850
  5. Kiss, Robert D.

    1. You have access
      Practicing Safe Cell Culture: Applied Process Designs for Minimizing Virus Contamination Risk
      Robert D. Kiss
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 715-729; DOI: https://doi.org/10.5731/pdajpst.2011.00852
  6. Kljavin, Ivar J.

    1. You have access
      Broadening Our Expectations for Viral Safety Risk Mitigation
      Ivar J. Kljavin
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 645-653; DOI: https://doi.org/10.5731/pdajpst.2011.00833
  7. Kolman, J. L.

    1. You have access
      Massively Parallel Sequencing for the Detection of Adventitious Viruses
      J. L. Kolman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 663-667; DOI: https://doi.org/10.5731/pdajpst.2011.00836
  8. Kozlowski, Steven

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820
  9. Krause, Philip R.

    1. You have access
      Use of DOP-PCR in Non-Specific Virus Detection
      Christine Uhlenhaut, Shasta McClenahan and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 681-684; DOI: https://doi.org/10.5731/pdajpst.2011.00842
    2. You have access
      Regulatory Approaches for Control of Viral Contamination of Vaccines
      Shasta McClenahan, Christine Uhlenhaut and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 557-562; DOI: https://doi.org/10.5731/pdajpst.2011.00819

L

  1. Lawrence, Bill

    1. You have access
      Evaluation of a Single-Platform, Rapid, Nucleic Acid–Based Technology for Detection of Adventitious Contaminants of Cell Culture
      Houman Dehghani, Bill Lawrence and Richard C. Ill
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 675-680; DOI: https://doi.org/10.5731/pdajpst.2011.00840
  2. Lubiniecki, Anthony

    1. You have access
      Summary of Breakout Session E
      Kurt Brorson and Anthony Lubiniecki
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 616-619; DOI: https://doi.org/10.5731/pdajpst.2011.00828
  3. Lubiniecki, Anthony S.

    1. You have access
      Evolution of Approaches to Viral Safety Issues for Biological Products
      Anthony S. Lubiniecki
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 547-556; DOI: https://doi.org/10.5731/pdajpst.2011.00818
  4. Lutgen, Mark

    1. You have access
      Chlorine Dioxide Remediation of a Virus-Contaminated Manufacturing Facility
      Mark Lutgen
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 620-624; DOI: https://doi.org/10.5731/pdajpst.2011.00830

M

  1. Ma, Hailun

    1. You have access
      Detection of Latent Retroviruses in Vaccine-related Cell Substrates: Investigation of RT Activity Produced by Chemical Induction of Vero Cells
      Hailun Ma and Arifa S. Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 685-689; DOI: https://doi.org/10.5731/pdajpst.2011.00843
  2. McClenahan, Shasta

    1. You have access
      Use of DOP-PCR in Non-Specific Virus Detection
      Christine Uhlenhaut, Shasta McClenahan and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 681-684; DOI: https://doi.org/10.5731/pdajpst.2011.00842
    2. You have access
      Regulatory Approaches for Control of Viral Contamination of Vaccines
      Shasta McClenahan, Christine Uhlenhaut and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 557-562; DOI: https://doi.org/10.5731/pdajpst.2011.00819
  3. McLoughlin, Kevin

    1. You have access
      Detection of Adventitious Viruses from Biologicals Using a Broad-Spectrum Microbial Detection Array
      Crystal Jaing, Shea Gardner, Kevin McLoughlin, James B. Thissen and Tom Slezak
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 668-674; DOI: https://doi.org/10.5731/pdajpst.2011.00838
  4. Moody, Mark

    1. You have access
      Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
      Mark Moody, Washington Alves, Jose Varghese and Fazal Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 580-588; DOI: https://doi.org/10.5731/pdajpst.2011.00824
  5. Morrow, Michael

    1. You have access
      Nanostring's nCounter—A True Digital Target Profiling Technology
      Michael Morrow and John Donaldson
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 692; DOI: https://doi.org/10.5731/pdajpst.2011.00841
  6. Munroe, David

    1. You have access
      A Microarray Platform for Virus Detection and Identification
      David Munroe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 691; DOI: https://doi.org/10.5731/pdajpst.2011.00839

N

  1. Norwood, Laurie P.

    1. You have access
      Summary of Breakout Session F: Facility and Equipment Decontamination Strategies
      Laurie P. Norwood and Kalavati Suvarna
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 625-626; DOI: https://doi.org/10.5731/pdajpst.2011.00829

O

  1. Onions, David

    1. You have access
      Overview of Emerging Technologies To Detect Adventitious Agents
      David Onions
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 654-659; DOI: https://doi.org/10.5731/pdajpst.2011.00834

P

  1. Pennathur, Sridhar

    1. You have access
      Application of Risk Assessments in the Design of the Overall Viral Control Strategy Used during the Manufacture and Testing of Live Virus Vaccines
      Sridhar Pennathur
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 730-736; DOI: https://doi.org/10.5731/pdajpst.2011.00851
  2. Piérard, Isabelle

    1. You have access
      Contamination by Porcine Circovirus Type 1: Findings, Investigations, and Learnings
      Isabelle Piérard
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 614; DOI: https://doi.org/10.5731/pdajpst.2011.00826

R

  1. Ranucci, C. S.

    1. You have access
      Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus
      C. S. Ranucci, T. Tagmyer and P. Duncan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 589-598; DOI: https://doi.org/10.5731/pdajpst.2011.00827
  2. Rosenberg, Amy S.

    1. You have access
      Risk Mitigation Strategies for Viral Contamination of Biotechnology Products: Consideration of Best Practices
      Amy S. Rosenberg, Barry Cherney, Kurt Brorson, Kathleen Clouse, Steven Kozlowski, Patricia Hughes and Rick Friedman
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 563-567; DOI: https://doi.org/10.5731/pdajpst.2011.00820

S

  1. Sampath, Rangarajan

    1. You have access
      Advanced Techniques for Detection and Identification of Viral Contaminants Using the Ibis PLEX-ID Universal Biosensor
      Rangarajan Sampath
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 690; DOI: https://doi.org/10.5731/pdajpst.2011.00837
  2. Sausville, Robert

    1. You have access
      Summary of Breakout Session B: Regulatory Expectations for CGMP
      Robert Sausville and Chantal Cazeault
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 713-714; DOI: https://doi.org/10.5731/pdajpst.2011.00847
  3. Skrine, Jim

    1. You have access
      A Biotech Production Facility Contamination Case Study—Minute Mouse Virus
      Jim Skrine
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 599-611; DOI: https://doi.org/10.5731/pdajpst.2011.00823
  4. Slezak, Tom

    1. You have access
      Detection of Adventitious Viruses from Biologicals Using a Broad-Spectrum Microbial Detection Array
      Crystal Jaing, Shea Gardner, Kevin McLoughlin, James B. Thissen and Tom Slezak
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 668-674; DOI: https://doi.org/10.5731/pdajpst.2011.00838
  5. Suvarna, Kalavati

    1. You have access
      Summary of Breakout Session F: Facility and Equipment Decontamination Strategies
      Laurie P. Norwood and Kalavati Suvarna
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 625-626; DOI: https://doi.org/10.5731/pdajpst.2011.00829

T

  1. Tagmyer, T.

    1. You have access
      Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus
      C. S. Ranucci, T. Tagmyer and P. Duncan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 589-598; DOI: https://doi.org/10.5731/pdajpst.2011.00827
  2. Thissen, James B.

    1. You have access
      Detection of Adventitious Viruses from Biologicals Using a Broad-Spectrum Microbial Detection Array
      Crystal Jaing, Shea Gardner, Kevin McLoughlin, James B. Thissen and Tom Slezak
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 668-674; DOI: https://doi.org/10.5731/pdajpst.2011.00838

U

  1. Uhlenhaut, Christine

    1. You have access
      Use of DOP-PCR in Non-Specific Virus Detection
      Christine Uhlenhaut, Shasta McClenahan and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 681-684; DOI: https://doi.org/10.5731/pdajpst.2011.00842
    2. You have access
      Regulatory Approaches for Control of Viral Contamination of Vaccines
      Shasta McClenahan, Christine Uhlenhaut and Philip R. Krause
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 557-562; DOI: https://doi.org/10.5731/pdajpst.2011.00819

V

  1. Vacante, Dominick A.

    1. You have access
      Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
      Linda C. Hendricks and Dominick A. Vacante
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 612-613; DOI: https://doi.org/10.5731/pdajpst.2011.00825
  2. Varghese, Jose

    1. You have access
      Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
      Mark Moody, Washington Alves, Jose Varghese and Fazal Khan
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 580-588; DOI: https://doi.org/10.5731/pdajpst.2011.00824

W

  1. Wiebe, Michael

    1. You have access
      Introduction to Workshop: Adventitious Viruses in Biologics—Detection and Mitigation Strategies
      Arifa S. Khan, Patricia Hughes and Michael Wiebe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 544-546; DOI: https://doi.org/10.5731/pdajpst.2011.00817
    2. You have access
      PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document—A Progress Report
      Kathryn King and Michael Wiebe
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 693; DOI: https://doi.org/10.5731/pdajpst.2011.00844
  2. Willkommen, Hannelore

    1. You have access
      Breakout Session C Summary: Current Virus Detection Methods
      Andrew P. Byrnes and Hannelore Willkommen
      PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 660-662; DOI: https://doi.org/10.5731/pdajpst.2011.00835
Back to top
PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 65 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 65, Issue 6
November/December 2011
  • Table of Contents
  • Index by Author
Sign up for Alerts

  • Most Cited
  • Most Read
Loading
  • A New Integrated Modeling Approach with Case Studies for Gas Transmission of Container Closure Headspace
  • A Commentary on Several Study Design Considerations Pertaining to the Screening of Substances Extracted and/or Leached from Pharmaceutical Contact Materials
  • Low-Volume Aseptic Filling Using a Linear Peristaltic Pump
  • The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
More...

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire